US 2023/0414609 A1Published application

Uses of orai1-specific calcium channels in treatment of oral cancer

OwnerRodrigo Lacruz, Ga-Yeon Soninventors

Life of this patent

Estimating the term…

Abstract

Provided are methods for treating oral cancer and inhibition allodynia. The methods involve administering to an individual who has oral cancer one or more agents that can inhibit ORAI Ca2+ channels.

Claims7

Dependent claims

A method comprising administering to an individual who has oral cancer a composition comprising a calcium channel blocker.

Dependencies are inferred from the claim text.

Facts

Application: 18/339,773Filed 22 Jun 2023
Priority: 22 Jun 2022
Published: 28 Dec 2023
Term ends: Not estimatedThe source records don’t support an estimate.

Classification7 codes

A61K 31/497
Non-condensed pyrazines: containing further heterocyclic rings
A61K 31/415
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: 1,2-Diazoles
A61K 31/433
Having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole: thidiazoles
A61K 31/44
Having six-membered rings with one nitrogen as the only ring hetero atom: non condensed pyridines; Hydrogenated derivatives thereof

Family

Application63/354,614Us provisional application · filed 22 Jun 2022
US 2023/0414609 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results